Compare Payoneer Global Inc (PAYO) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Payoneer Global Inc vs Recursion Pharmaceuticals Inc — how do they compare? Payoneer Global Inc trades at $7.13 (market cap $2.41B), while Recursion Pharmaceuticals Inc trades at $3 (market cap $1.63B). The key difference: Payoneer Global Inc is the larger of the two by market cap, and Payoneer Global Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| PAYO | RXRX | |
|---|---|---|
Market Cap | $2.41B | $1.63B |
Sector | Technology | Health |
52-Week High | $7.42 | $6.79 |
52-Week Low | $4.27 | $2.84 |
Enterprise Value | $2.15B | $1.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
